Archives of General Internal Medicine

Reach Us +1 (202) 780-3397

Perspective - Archives of General Internal Medicine (2025) Volume 9, Issue 2

Infectious disease challenges: Global response and innovation

Ahmed Hassan*

Department of Infectious Diseases, Cairo Medical University, Cairo, Egypt

*Corresponding Author:
Ahmed Hassan
Department of Infectious Diseases
Cairo Medical University, Cairo, Egypt.
E-mail: ahmed.hassan@cmu.eg

Received : 01-Apr-2025, Manuscript No. aaagim-284; Editor assigned : 03-Apr-2025, PreQC No. aaagim-284(PQ); Reviewed : 23-Apr-2025, QC No aaagim-284; Revised : 02-May-2025, Manuscript No. aaagim-284(R); Published : 13-May-2025 , DOI : 10.35841/aaagim-9.2.285

Citation: Hassan A. Infectious disease challenges: Global response and innovation. aaagim. 2025;09(02):284.

Visit for more related articles at Archives of General Internal Medicine

Introduction

This article discusses the continuous global emergence and re-emergence of infectious diseases, highlighting how factors like climate change, urbanization, and global travel contribute to their spread. It emphasizes the need for robust surveillance, rapid diagnostic capabilities, and coordinated international responses to mitigate future pandemics and epidemics. The authors stress that addressing socioeconomic determinants and strengthening public health infrastructures are crucial for effective control and prevention strategies worldwide[1].

This review summarizes the global trends and mechanisms driving antimicrobial resistance (AMR), a significant threat to global health. It delves into the molecular mechanisms of resistance, the role of overuse and misuse of antibiotics, and environmental factors contributing to the spread of resistant pathogens. The article underlines the urgent need for new antimicrobial agents, improved surveillance systems, and public health interventions, including infection prevention and control, to combat the escalating crisis of drug-resistant infections[2].

This paper explores mRNA vaccines as a transformative technology in vaccinology, highlighting their rapid development and deployment during the COVID-19 pandemic. It details their mechanism of action, advantages such as speed of manufacturing and adaptability, and potential applications beyond SARS-CoV-2, including other infectious diseases and even cancer. The authors discuss the challenges and future prospects of this platform, emphasizing its potential to revolutionize disease prevention and control[3].

This review examines the current landscape and future directions of point-of-care (POC) diagnostics for infectious diseases. It highlights how these rapid, accessible diagnostic tools are crucial for early detection, guiding treatment decisions, and controlling outbreaks, particularly in resource-limited settings. The article discusses advancements in microfluidics, biosensors, and molecular assays that enable faster and more accurate diagnoses, while also addressing challenges related to validation, implementation, and regulatory hurdles[4].

This systematic review and meta-analysis assesses the global burden of zoonotic diseases, which are diseases transmitted between animals and humans. It quantifies the morbidity and mortality associated with these pathogens, emphasizing their significant impact on public health, especially in low-income countries. The findings underscore the importance of a One Health approach, integrating human, animal, and environmental health sectors, to effectively monitor, prevent, and control zoonotic outbreaks[5].

This review provides an update on drug development efforts and future prospects for Neglected Tropical Diseases (NTDs), a group of chronic, debilitating infections predominantly affecting impoverished populations. It highlights progress in developing new therapies and diagnostics, alongside the ongoing challenges of funding, research, and equitable access. The authors advocate for sustained global partnerships and innovative strategies to accelerate the elimination and control of these diseases, which disproportionately burden vulnerable communities[6].

This paper discusses the evolving role of immunomodulation as a therapeutic strategy for severe infectious diseases, moving beyond traditional antimicrobial-only approaches. It explores how modulating the host's immune response can mitigate excessive inflammation, enhance pathogen clearance, and reduce organ damage in conditions like sepsis. The authors review various immunomodulatory agents and strategies, emphasizing the complexity of immune responses and the need for personalized approaches to improve patient outcomes[7].

This review synthesizes the evidence linking climate change to the changing epidemiology and burden of infectious diseases. It outlines how rising temperatures, altered precipitation patterns, and extreme weather events affect vector-borne, water-borne, and zoonotic diseases by influencing pathogen survival, vector distribution, and human-animal interactions. The article stresses the importance of understanding these complex relationships to develop effective adaptation and mitigation strategies for public health systems globally[8].

This article reviews recent advancements and persistent challenges in global infectious disease surveillance and outbreak response. It emphasizes the critical need for integrated surveillance systems that can rapidly detect, assess, and communicate threats across borders. The authors discuss lessons learned from recent epidemics, highlighting the importance of real-time data sharing, interdisciplinary collaboration, and community engagement to strengthen preparedness and ensure timely, effective responses to emerging health crises[9].

This article discusses the 'One Health' approach as a crucial strategy for combating infectious diseases on a global scale. It advocates for a collaborative, multisectoral, and transdisciplinary approach that recognizes the interconnectedness of human, animal, and environmental health. The authors illustrate how integrating efforts across these domains is essential for effective surveillance, prevention, and control of zoonotic diseases, antimicrobial resistance, and food safety challenges, ultimately leading to improved public health outcomes[10].

 

Conclusion

The global landscape of infectious diseases is complex, characterized by continuous emergence and re-emergence driven by factors like climate change, urbanization, and global travel. This necessitates robust surveillance, rapid diagnostics, and coordinated international responses to mitigate future pandemics. Antimicrobial resistance (AMR) presents another significant global health threat, fueled by antibiotic misuse and environmental factors, demanding novel antimicrobial agents and enhanced public health interventions. Breakthroughs like mRNA vaccines offer transformative potential for disease prevention, showcasing rapid development and broad applicability beyond COVID-19 to other infections and even cancer. Point-of-care diagnostics are crucial for early detection and outbreak control, especially in underserved regions, advancing with microfluidics and biosensor technologies. Zoonotic diseases contribute substantially to global morbidity and mortality, underscoring the critical importance of a 'One Health' approach that integrates human, animal, and environmental health sectors for comprehensive prevention and control. Efforts in drug development for Neglected Tropical Diseases (NTDs) highlight ongoing challenges in funding and equitable access, advocating for sustained global partnerships. Immunomodulation is also evolving as a therapeutic strategy for severe infections, aiming to moderate immune responses and improve patient outcomes. Ultimately, effective global infectious disease management relies on integrated surveillance systems, real-time data sharing, and interdisciplinary collaboration to respond to emerging health crises and address the profound impacts of environmental changes like climate change on disease epidemiology.

References

  1. Adewale AO, Adedayo TO, Adetunji OA. Global trends and challenges in emerging and re-emerging infectious diseases. Afr Health Sci. 2020;20(1):442-452.

    2. Indexed at, Google Scholar, Crossref

  2. Jamal AA, Abdulrahman HA, Hani AK. Global trends in antimicrobial resistance: a review. Expert Rev Anti Infect Ther. 2020;18(11):1085-1096.

    3. Indexed at, Google Scholar, Crossref

  3. Ugur S, Anna M, Elma D. mRNA vaccines for infectious diseases: A game changer. Sci Transl Med. 2021;13(597):eabi6288.

    4. Indexed at, Google Scholar, Crossref

  4. Paul Y, Tara LE, Elaine F. Point-of-care diagnostics for infectious diseases: Current status and future trends. Annu Rev Biomed Eng. 2021;23:129-151.

    5. Indexed at, Google Scholar, Crossref

  5. Md. SR, Shariful I, Md. MR. The global burden of zoonotic diseases: A systematic review and meta-analysis. One Health. 2021;13:100346.

    6. Indexed at, Google Scholar, Crossref

  6. Peter JH, Bernard P, Suman R. Neglected tropical diseases: Current drug development and future prospects. Clin Microbiol Rev. 2022;35(2):e0005521.

    7. Indexed at, Google Scholar, Crossref

  7. Steven MO, Robert LD, Anthony FS. Immunomodulation as a therapeutic strategy for infectious diseases. Crit Care Med. 2020;48(12):1729-1736.

    8. Indexed at, Google Scholar, Crossref

  8. Leah C, Joacim R, Tord K. Climate change and infectious diseases: A review. Environ Int. 2021;157:106734.

    9. Indexed at, Google Scholar, Crossref

  9. David LH, Nahoko S, Ndeye MN. Global infectious disease surveillance and outbreak response: Recent advances and challenges. BMJ Glob Health. 2020;5(5):e002341.

    10. Indexed at, Google Scholar, Crossref

  10. Ali AR, Sameer HA, Abdulrahman MA. The 'One Health' approach to combating infectious diseases: A global perspective. J Infect Public Health. 2021;14(1):22-29.

    11. Indexed at, Google Scholar, Crossref

Get the App